Page last updated: 2024-12-06

indoxyl phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Indoxyl phosphate (IP) is a compound formed in the liver during the metabolism of tryptophan. It is a potential biomarker for kidney function, as its levels in the blood increase when the kidneys are not functioning properly. IP is synthesized from indoxyl sulfate, which is produced by the liver during the metabolism of tryptophan. IP can accumulate in the blood and tissues of patients with chronic kidney disease (CKD), and it has been linked to several complications of CKD, including cardiovascular disease, anemia, and bone disease. The accumulation of IP is thought to contribute to these complications by inducing oxidative stress and inflammation. IP is also being studied as a potential therapeutic target for CKD. The enzyme indoxyl sulfatase (IS) is responsible for the breakdown of IP. Studies are being conducted to develop drugs that can inhibit IS, thereby reducing the levels of IP in the blood and potentially improving the outcomes of patients with CKD.'

indoxyl phosphate: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID26292
SCHEMBL ID540158
MeSH IDM0105263

Synonyms (10)

Synonym
indoxylphosphate
1h-indol-3-yl dihydrogen phosphate
indoxyl phosphate
13822-19-0
1h-indol-3-ol, dihydrogen phosphate (ester)
SCHEMBL540158
DTXSID60160538
disodium,1h-indol-3-yl phosphate
FD10325
PD150848
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.41 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]